GSIHX
Price
$20.59
Change
-$0.18 (-0.87%)
Updated
Feb 21 closing price
Net Assets
47.78B
RERBX
Price
$54.18
Change
-$0.50 (-0.91%)
Updated
Feb 21 closing price
Net Assets
131.04B
Ad is loading...

GSIHX vs RERBX

Header iconGSIHX vs RERBX Comparison
Open Charts GSIHX vs RERBXBanner chart's image
Goldman Sachs GQG Ptnrs Intl Opps A
Price$20.59
Change-$0.18 (-0.87%)
VolumeN/A
Net Assets47.78B
American Funds Europacific Growth R2
Price$54.18
Change-$0.50 (-0.91%)
VolumeN/A
Net Assets131.04B
GSIHX vs RERBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSIHX vs. RERBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSIHX is a Buy and RERBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 131B vs. GSIHX (47.8B). GSIHX pays higher dividends than RERBX: GSIHX (1.80) vs RERBX (1.00). GSIHX was incepted earlier than RERBX: GSIHX (8 years) vs RERBX (23 years). GSIHX is a more actively managed with annual turnover of: 62.00 vs. RERBX (34.00). RERBX has a lower initial minimum investment than GSIHX: RERBX (250) vs GSIHX (1000). RERBX annual gain was more profitable for investors over the last year : 0.62 vs. GSIHX (-3.01). GSIHX return over 5 years is better than : 43.04 vs. RERBX (4.32).
GSIHXRERBXGSIHX / RERBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD6.0256.54992%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets47.8B131B36%
Annual Yield % from dividends1.801.00180%
Returns for 1 year-3.010.62-486%
Returns for 3 years15.84-0.32-5,010%
Returns for 5 years43.044.32996%
Returns for 10 yearsN/A15.57-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KFS7.66-0.01
-0.13%
Kingsway Financial Services
ENLV1.00-0.02
-1.81%
Enlivex Therapeutics Ltd
PGRE4.52-0.10
-2.16%
Paramount Group
PTC161.65-4.11
-2.48%
PTC
RNA31.12-1.41
-4.33%
Avidity Biosciences